Q2 2023 Earnings Presentation

Q2 FY23 financial results Revenue by Business Q2 FY23 11% Devices 53% Masks and other 36% OOH SaaS Revenue by Region Q2 FY23 ■U.S., Canada, Revenue ($M) Non-GAAP Operating Income ($M) Non-GAAP EPS $1,033.7 $894.9 $267.7 $305.5 $1.66 $1.47 11% and Latin America ■ Europe, Asia, Q2 FY22 Q2 FY23 Q2 FY22 Q2 FY23 Q2 FY22 Q2 FY23 29% and Other 60% ■OOH SaaS NOTE: See reconciliation to GAAP in Appendix 8 2023 ResMed | Q2 2023 Earnings Presentation - Jan. 26, 2023 ResMed

View entire presentation